Find medicine
What's new
FAQs
Latest news
Review will look into risk of agranulocytosis, a sudden drop in white blood cells that can lead to serious infections, and measures to minimise it.
Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines.
Board adopts Executive Director’s annual activity report for 2023 and hears updates on implementation of new fee regulation.
Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2024.
EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its May 2024 meeting
Events
EMA is hosting the twelfth industry stakeholder platform on the operation of the centralised procedure for human medicines on 19 June 2024.